Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ABT-874 vs Methotrexate in moderate to severe chronic plaque psoriasis
NCT00679731Phase 3Completed
- Sponsor
- AbbVie Inc.
- Start
- Apr 2008
- Primary completion
- Nov 2009
- Countries
- 14
01
Overview
A Phase 3 trial of briakinumab in plaque psoriasis, sponsored by AbbVie Inc.. Started Apr 2008; status: completed.
02
Drugs
briakinumab
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT00679731.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00679731.